Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX)
Clinical trial NCT04787354 · RECRUITING
Trial details
- NCT number
- NCT04787354
- Sponsor
- Hallym University Medical Center
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2024-12-31
- Enrollment
- 976
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.